FDCDDQ
BCYC

Federation des caisses Desjardins du Quebec’s Bicycle Therapeutics BCYC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.5K Hold
14,302
– – ﹤0.01% 1788
2025
Q4 		$101K Hold
14,302
– – ﹤0.01% 1665
2025
Q3 		$111K Buy
14,302
+4,699
+49% +$35.5K ﹤0.01% 1609
2025
Q2 		$66.8K Buy
9,603
+9,542
+15,643% +$76K ﹤0.01% 1475
2025
Q1 		$518 Hold
61
– – ﹤0.01% 2483
2024
Q4 		$854 Hold
61
– – ﹤0.01% 2336
2024
Q3 		$1.38K Hold
61
– – ﹤0.01% 2284
2024
Q2 		$1.24K Buy
+61
New +$1.38K ﹤0.01% 2166

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BCYC Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Bicycle Therapeutics (BCYC) position steady in Q1 2026 at 14,302 shares worth $66.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1788.

Federation des caisses Desjardins du Quebec first reported a position in BCYC in Q2 2024 and has held it in 8 quarters since. The position peaked at $111K in Q3 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 14,302 shares of Bicycle Therapeutics worth $66.5K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Bicycle Therapeutics share count unchanged in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1788 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Federation des caisses Desjardins du Quebec's Bicycle Therapeutics position peaked at $111K in Q3 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.